Dual inhibition of the TrkA and JAK2 pathways using entrectinib and pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers is a research paper published in Cancer Letters (2024). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1T32CA247819-03
National Institutes of Health
Grant: R01CA228137
US Department of Defense
Grant: W81XWH-19-1-0072
US Department of Defense
Grant: W81XWH-20-1-0044
US Department of Defense
Grant: W81XWH-19-1-0753
NCI NIH HHS
Grant: T32 CA247819
METAvivor
American Association for Cancer Research
FWCI
3.07
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals